Showing results (871-880 of 1,211) with videos related to
Sort By:
Pageof 122
JACC. Heart Failure|July 28, 2022
Effects of Dapagliflozin According to the Heart Failure Collaboratory Medical Therapy Score: Insights From DAPA-HFJawad H Butt, Pooja Dewan, Ersilia M DeFilippis, et al.JACC. Heart Failure|April 10, 2025
Finerenone Across the Spectrum of Kidney Risk in Heart Failure: The FINEARTS-HF TrialJohn W Ostrominski, Finnian R Mc Causland, Brian L Claggett, et al.European Heart Journal|April 21, 2017
Risk of stroke in chronic heart failure patients with preserved ejection fraction, but without atrial fibrillation: analysis of the CHARM-Preserved and I-Preserve trialsAzmil H Abdul-Rahim, Ana-Cristina Perez, Rachael L MacIsaac, et al.Circulation. Heart Failure|January 13, 2016
Risk Related to Pre-Diabetes Mellitus and Diabetes Mellitus in Heart Failure With Reduced Ejection Fraction: Insights From Prospective Comparison of ARNI With ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure TrialSøren L Kristensen, David Preiss, Pardeep S Jhund, et al.Journal of the American Heart Association|February 1, 2021
Clinical Characteristics and Outcomes of Patients With Heart Failure With Reduced Ejection Fraction and Chronic Obstructive Pulmonary Disease: Insights From PARADIGM-HFSolmaz Ehteshami-Afshar, Leanne Mooney, Pooja Dewan, et al.European Heart Journal|March 24, 2022
Influence of atrial fibrillation on efficacy and safety of omecamtiv mecarbil in heart failure: the GALACTIC-HF trialScott D Solomon, Brian L Claggett, Zi Michael Miao, et al.Lancet (London, England)|March 8, 2023
Electronic nudges to increase influenza vaccination uptake in Denmark: a nationwide, pragmatic, registry-based, randomised implementation trialNiklas Dyrby Johansen, Muthiah Vaduganathan, Ankeet S Bhatt, et al.Journal of the American College of Cardiology|July 30, 2025
Guideline-Directed Medical Therapy and Outcomes Among Patients With Heart Failure With Improved Ejection FractionKyung H Min, Alan S Go, Keane Lee, et al.European Heart Journal|January 28, 2025
Near-universal prevalence of central adiposity in heart failure with preserved ejection fraction: the PARAGON-HF trialAlexander Peikert, Muthiah Vaduganathan, Brian L Claggett, et al.The Lancet. Diabetes & Endocrinology|January 16, 2025
Finerenone and new-onset diabetes in heart failure: a prespecified analysis of the FINEARTS-HF trialJawad H Butt, Pardeep S Jhund, Alasdair D Henderson, et al.Pageof 122